Cholestasis Global Clinical Trials Review, H2, 2018

2018-12-31
Cholestasis Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cholestasis Global Clinical Trials Review, H2, 2018” provides an overview of Cholestasis clinical trials scenario. This report...

Cerebral Palsy Global Clinical Trials Review, H2, 2018

2018-12-31
Cerebral Palsy Global Clinical Trials Review, H2, 2018 Summary GlobalData’s clinical trial report, “Cerebral Palsy Global Clinical Trials Review, H2, 2018” provides an overview of Cerebral Palsy clinical trials scenario. This...

Competitor Landscape: Sjogren’s Syndrome

2018-12-30
Competitor Landscape: Sjögren’s Syndrome Summary Sociable Pharma’s ‘Treatment Landscape’ contains evaluations of ongoing development activities within the Sjögren’s Syndrome market, analysis of current & potential future...

Age-Related Macular Degeneration: Competitive Landscape to 2026

2018-12-21
Age-Related Macular Degeneration: Competitive Landscape to 2026 Summary Age-Related macular degeneration (AMD) is one of the leading cause of vision loss among people ages 50 and over in the developed world, characterized by the deterioration...

Glaucoma: Competitive Landscape to 2026

2018-12-21
Glaucoma: Competitive Landscape to 2026 Summary Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes...

Plaque Psoriasis: Epidemiology Forecast to 2027

2018-12-20
Plaque Psoriasis: Epidemiology Forecast to 2027 Summary Plaque psoriasis is a chronic immune-mediated skin disease characterized by red, flaky patches that are itchy and sometimes painful. Psoriatic plaques are formed due to an increased production...

Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals

2018-12-20
Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals Summary GlobalData’s “Partnerships, Licensing, Investments and M&A Deals and Trends for October 2018 in Pharmaceuticals”,...

Psoriatic Arthritis: Competitive Landscape to 2026

2018-12-19
Psoriatic Arthritis: Competitive Landscape to 2026 Summary Psoriatic arthritis is a chronic immune-mediated arthritis that typically affects the large joints, including those of the lower extremities, the distal joints of the fingers and toes,...

PharmSource – M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition

2018-12-19
PharmSource – M&A in the Contract Manufacturing Industry: Implications and Outlook – 2018 Edition Summary This report is the 2nd edition of our analysis of Mergers and Acquisitions in the contract manufacturing industry. PharmSource...

Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027

2018-12-19
Plaque Psoriasis: Global Drug Forecast and Market Analysis to 2027 Summary Psoriasis is an incurable, chronic and systemic inflammatory skin disorder with a prevalence of 2-3% worldwide. The exact causes of psoriasis is unknown, although it...
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy